Cosgrove Chris MD is categorized under Physicians Offices in Wilmington, NC and active since 2007.
Cosgrove Chris MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Chris Cosgrove at the company’s single location by writing to 4114 Shipyard Boulevard, Wilmington, North Carolina NC 28403 or by phoning (910) 332-0701. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cosgrove Chris MD |
| Contact Person: | Chris Cosgrove |
| Address: | 4114 Shipyard Boulevard, Wilmington, North Carolina 28403 |
| Phone Number: | (910) 332-0701 |
| Website Address: | intracoastalmedicine.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Cosgrove Chris MD was started in 2007 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Chris Cosgrove for inquiries that concern Cosgrove Chris MD by calling the company number (910) 332-0701, as your correspondence is most welcome. Additionally, the physical location of the single location of Cosgrove Chris MD can be found at the coordinates 34.19808,-77.89493 as well as the street address 4114 Shipyard Boulevard in Wilmington, North Carolina 28403.
For its online presence, you may visit Cosgrove Chris MD’s website at intracoastalmedicine.com and engage with its social media outlets through on Twitter and on Facebook.